Fever-Tree’s international expansion will be in the spotlight when it updates investors this week.
The firm, which makes tonic water and other mixers, has been focused on cracking the US market after a slump in UK sales growth.
Shares fizzed when Fever-Tree earlier this year announced that Molson Coors had bought an 8.5 per cent stake in the business for £71m.
The tie-up with the US brewer is part of a plan to drive further growth in America – which has become the Aim-listed firm’s largest market.
Losing its fizz: Fever-Tree has been focused on cracking the US market after a slump in UK sales growth
But analysts expect Fever-Tree to reiterate its low single digit sales growth guidance for the full year in a trading update on Thursday.
The Molson Coors partnership ‘is expected to help drive the next leg of growth in North America,’ Hargreaves Lansdown analyst Aarin Chiekrie said.
DIY INVESTING PLATFORMS
AJ Bell
AJ Bell
Easy investing and ready-made portfolios
Hargreaves Lansdown
Hargreaves Lansdown
Free fund dealing and investment ideas
interactive investor
interactive investor
Flat-fee investing from £4.99 per month
InvestEngine
InvestEngine
Account and trading fee-free ETF investing
Trading 212
Trading 212
Free share dealing and no account fee
Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.
